Biblio Discovery — Demo Discovery Service

4 results for "S. B. Stephan"

Showing 1–4 · 0.92 seconds · RSS

  1. Journal Article

    Liquid foam improves potency and safety of gene therapy vectors

    K. Fitzgerald; S. B. Stephan; N. Ma et al.

    Nature Communications, Vol. 15 No. 1 · 2024 · English · DOAJ Scopus

    Abstract Interest in gene therapy medicines is intensifying as the first wave of gene-correcting drugs is now reaching patient populations. However, efficacy and safety concerns, laborious manufacturing protocols, and the high cost of the therapeutics are still significant barriers in gene therapy…

  2. Journal Article

    In vitro-transcribed antigen receptor mRNA nanocarriers for transient expression in circulating T cells in vivo

    N. N. Parayath; S. B. Stephan; A. L. Koehne et al.

    Nature Communications, Vol. 11 No. 1 · 2020 · English · DOAJ Scopus

    Ex vivo engineering of antigen-specific T cells has shown therapeutic efficacy but can be costly and scarce. Here the authors show that in vitro-transcribed antigen receptor mRNA packaged in nanocarriers can directly induce, in vivo, transient their expression in circulating T cells to provide…

  3. Journal Article

    Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers

    F. Zhang; N. N. Parayath; C. I. Ene et al.

    Nature Communications, Vol. 10 No. 1 · 2019 · English · DOAJ Scopus

    The previous efforts to reprogramme tumour-associated macrophages (TAMs) to M1 phenotype have caused undesired side-effects. Here, the authors report targeted nanocarriers for delivering mRNA encoding M1-polarizing transcription factors to TAMs and show their efficacy in multiple mouse tumour…

  4. Journal Article

    Hit-and-run programming of therapeutic cytoreagents using mRNA nanocarriers

    H. F. Moffett; M. E. Coon; S. Radtke et al.

    Nature Communications, Vol. 8 No. 1 · 2017 · English · DOAJ Scopus

    Current widely used viral and electroporation methods for creating therapeutic cell-based products are complex and expensive. Here, the authors develop targeted mRNA nanocarriers that can transiently program gene expression by simply mixing them with cells, to improve their therapeutic potential.